Brief: Vanda Announces FDA Grants Landmark Hearing For Hetlioz® In Jet Lag Disorder, The First Drug Approval Hearing In Over 40 Years
03/03/2026 13:11
March 3 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O: VANDA ANNOUNCES FDA GRANTS LANDMARK HEARING FOR HETLIOZ® IN JET LAG DISORDER, THE FIRST DRUG APPROVAL HEARING IN OVER 40 YEARS Source text: ID:nPn6mmzrYa Further company coverage: VNDA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program